Академический Документы
Профессиональный Документы
Культура Документы
a r t i c l e i n f o a b s t r a c t
Article history: Background: The role of chorioamnionitis in neurodevelopment of preterm infants is not fully understood.
Received 2 September 2010 Aim: To examine the association between different indicators of intrauterine inammation (clinical
Received in revised form 20 December 2010 chorioamnionitis, histological chorioamnionitis and funisitis) and neurodevelopmental impairment in very
Accepted 3 January 2011 preterm infants.
Methods: Preterm infants with a birth weight of b 1500 g or a gestational age of b 32 weeks were included.
Keywords:
Follow-up evaluation up to 2 years of age consisted of neurological examination, neurodevelopmental
Chorioamnionitis
Funisitis
assessment and visual and audiologic tests. Outcome data were compared between the chorioamnionitis and
Neurodevelopmental outcome the control groups, controlling for gestational age, birth weight and Apgar score at 5 min.
Premature infant Results: One hundred seventy-seven patients comprised the study population (mean gestational age 29
Cerebral palsy 2 weeks, mean birth weight 1167 344 g). Histological chorioamnionitis was present in 49% of placentas,
Intraventricular hemorrhage whereas funisitis was observed in 25%. In 57% cases clinical maternal chorioamnionitis was suspected.
Periventricular leukomalacia Follow-up was available for 130 (82%) patients. Infants with funisitis, compared with controls, had a
signicantly higher incidence of moderate to severe disability (18% vs 5%, OR 4.07; 95% CI 1.1015.09).
Conclusion: The results of this study suggest that, unlike a broad denition of histological chorioamnionitis
including inammation of maternal or fetal placental tissues, funisitis may entail a higher risk of moderate to
severe disability at 2 years of age in preterm infants.
2011 Elsevier Ireland Ltd. All rights reserved.
0378-3782/$ see front matter 2011 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.earlhumdev.2011.01.024
254 N. Rovira et al. / Early Human Development 87 (2011) 253257
Although the relationship between chorioamnionitis, PVL and CP Outcome data were compared between groups: histological
in the preterm infant has been more extensively studied, there is chorioamnionitis present/absent; funsitis present/absent; and clinical
less information on the effect of choriomionitis on other areas of chorioamnionitis present/absent. Categorical variables were expressed
neurodevelopment, such as cognitive and speech development and as counts and percentages. Continuous variables were expressed as
sensorineural functions [13,15,17,23,31,36]. mean and standard deviation (M SD) if normally distributed and as
We hypothesized that exposure to chorioamnionitis would be median and range if not normally distributed. Categorical variables
associated with unfavorable neurodevelopmental outcome among were compared between groups using chi-square or Fisher exact test
children born very preterm. The objective of our study was to examine where appropriate. Continuous variables were compared using Student
the relationship between in utero (maternal or fetal) infection/ T test or MannWhitney U test. Univariate analysis was performed to
inammation and neurodevelopment at 2 years of age, differentiating look for an association between outcome variables and multiple birth,
between clinically apparent and subclinical processes. gestational age, birth weight or Apgar score at 5 min. We performed
binomial logistic regression or linear regression analysis to adjust for
2. Methods statistically signicant dichotomous or continuous confounding vari-
ables. A P valueb 0.05 was considered signicant. For risk estimates
All preterm infants born at Sant Joan de Du Hospital, a University odds ratios (ORs) and 95% condence intervals (CIs) were calculated
Tertiary Hospital, from January 2002 to December 2004 with a and adjusted for confounding variables by logistic regression analysis.
gestational age of b32 weeks or a birth weight of b1500 g were ORs were considered to represent a signicant association if the CIs did
included. Patients were excluded if: malformations, genetic or not include 1.00. Statistical analysis was performed using the SPSS
chromosomal syndromes or other causes of neurodevelopmental package.
disability or sensorineural decit not related to prematurity were
present; histopathological evaluation of the placenta had not been 3. Results
performed; or infants were products of multiple pregnancy, histolog-
ical characteristics of the placentas were discordant and had not been During the study period, 225 preterm infants with a gestational
assigned to each of the siblings. age of b32 weeks or a birth weight of b1500 g were born in our center.
Neonatal and neurodevelopmental outcome data were collected Nineteen were excluded due to the following clinical criteria: 2
from a prospective data base. Information regarding maternal clinical central nervous system malformations, 3 multiple congenital anoma-
status at delivery was obtained by reviewing maternal clinical records. lies syndromes, 2 pulmonary malformations, 7 congenital heart
For the purpose of this study, histology of the placentas was reviewed diseases, 1 neuromuscular disorder, 1 middle ear malformation, 1
by a pathologist (VC). congenital CMV infection and 2 trisomies; in 18 cases histological
Histological chorioamnionitis was dened as neutrophil inltration analysis of the placenta was not available; and 11 were product of
of amniotic membranes, umbilical cord or chorionic plate. Funisitis multiple pregnancy, histological characteristics of the placentas were
was considered if neutrophil inltration of umbilical vessel walls or discordant and had not been assigned to each of the siblings. Thus, 177
Whartons jelly was found. Clinical chorioamnionitis was dened as patients met the study entry criteria. The mean gestational age at birth
maternal fever (38 C) during labor or maternal leukocytosis or was 29.2 2.6 weeks and the mean birth weight was 1167 344 g.
elevated CRP ( 15,000 leukocytes/mm3 + CRP 30 mg/L, CRP Analysis of the placentas showed histological choriamnionitis in
60 mg/L or 20,000 leukocytes/mm3), without another cause, or by 87 (49.2%) and funisitis in 45 (25.4%). In 36/45 (80%) cases of funisitis
the presence of foul-smelling or purulent amniotic uid. inammation involved the arteries, the vein and the Wharton's jelly;
Follow-up consisted in evaluations up to 24 months' corrected 5 (11.1%) showed inammation of the arteries and the vein; 2 (4.4%)
age performed by pediatrician, pediatric neurologist, psychologist, inammation of the arteries alone; 1 (2.2%) inammation of the
othorhinolaryngologist and ophthalmologist. Patients underwent arteries and the surrounding jelly and 1 (2.2%) isolated vein
neurological examinations and screening of developmental deviations involvement. Clinical chorioamnionitis was diagnosed in 50/87
[37] at 2, 4, 8, 12, 18 and 24 months' corrected age. Visual evaluation (57.5%) cases of histological chorioamnionitis, whereas in 6 cases of
included evoked potential and screening for refractive errors. Hearing 56 suspected clinical chorioamnionitis (10.7%) pathological analysis
screening was performed by brainstem auditory evoked potential. At of the placenta did not show inammation. Funisitis was more
2 years' corrected age, a pediatric psychologist evaluated psychomo- frequently present when chorioamnionitis was clinically apparent
tor development via the Bayley Scales of Infant Development II [38] or (68.0% vs 29.7%, P b 0.0001).
the BrunetLezine Scale [39] and performed behavioural assessment. Neonatal characteristics of patients are shown in Table 2. Cranial
Disabilities were classied as absent, mild, moderate or severe [40,41] ultrasound scans revealed higher rates of IVH in infants exposed to
(Table 1). histological chorioamnionitis (P = 0.044), funisitis (P = 0.036) and
clinical chorioamnionitis (P = 0.003). In addition, the rate of grade 3
Table 1
IVH or parenchymal cerebral hemorrhage was higher in the groups of
Classication of disabilities in preterm infants.
infants exposed to histological chorioamnionitis (P = 0.028) and
No disabilities clinical chorioamnionitis (P = 0.043). Severe cerebral lesions (grade
Mild disabilities Isolated speech disorder. 3 IVH, parenchymal haemorrhage and/or cystic PVL) were more
Minor motor abnormality (tremor, clumsiness). frequently observed amongst patients exposed to histological chor-
Mild sensorineural decit (partial and unilateral). ioamnionitis (P = 0.013), funisitis (P = 0.025) and maternal clinical
Mild behavioral disorder (hyperactivity).
Refractive disorders.
sings of chorioamnionitis (P = 0.014). However, adjustment for
Moderate disabilities Hemiplegia, diplegia or tetraparesis not impairing the gestational age, birth weight and Apgar scores at 5 min by means of
ability to walk. multivariate logistic regression analysis revealed no signicant
Partial sensorineural decit (partial bilateral or total association between the different indicators of intraamniotic infec-
unilateral).
tion/inammation and cranial ultrasonographic ndings.
Developmental quotient 7084.
Severe disabilities Motor decit impairing the ability to walk. Of the 158 patients who survived the neonatal period, follow-up
Total sensorineural decit (blindness or deafness). evaluations up to 2 years of age were available for 130 (82.2%).
Seizures requiring anticonvulsant treatment. Patients with neurodevelopmental assessment at 2 years and patients
Severe behavioral disorder (psychosis, autism). lost to follow-up were comparable for gestational age, Apgar scores at
Developmental quotient b 70.
5 min, IVH, days of mechanical ventilation, days of oxygen,
N. Rovira et al. / Early Human Development 87 (2011) 253257 255
Table 2
Neonatal characteristics of 177 infants grouped by the presence or absence of histological chorioamnionitis, funisitis and clinical chorioamnionitis.
Mltiple pregnancy no. (%) 15 (17.4%) 36 (40%) 0.001 8 (17.8%) 43 (32.5%) ns 13 (23.2%) 38 (31.4%) ns
Male sex no. (%) 48 (55.1%) 46 (51.1%) ns 22 (48.9%) 72 (54.5%) ns 29 (51.7%) 65 (53.7%) ns
Gestational age M SD wk 28.3 2.5 30.1 2.3 b 0.001 27.9 2.5 29.7 2.4 b 0.001 27.9 2.3 29.8 2.5 b0.001
Birth weight M SD g 1168 373 1165 316 ns 1145 413 1174 318 ns 1153 391 1173 322 ns
Apgar score at 5 min median (range) 9 (510) 9 (410) ns 9 (510) 9 (410) ns 9 (610) 9 (410) ns
Days of oxygen median (range) 2 (0144) 2 (070) ns 4 (080) 1.42 (0144) ns 4 (0144) 1 (080) ns
Days of MV median (range) 0.5 (054) 0.02 (090) ns 0.75 (054) 0.08 (090) ns 1 (028) 0 (090) ns
Death no. (%) 12 (13.8%) 7 (7.7%) nsa 7 (15.5%) 12 (9.0%) nsa 9 (16.0%) 10 (8.3%) nsa
Cranial ultrasonographic ndings (n = 85) (n = 89) (n = 43) (n = 131) (n = 54) (n = 120)
Any grade IVH [42] no. (%) 18 (21.1%) 9 (10.1%) nsa 11 (25.6%) 16 (12.2%) nsa 15 (27.8%) 12 (10.0%) nsa
Grade 3 IVH or PH no. (%) 12 (14.1%) 4 (4.5%) nsa 6 (13.9%) 10 (7.6%) nsa 9 (16.7%) 7 (5.8%) nsa
Cystic PVL [43] no. (%) 3 (3.5%) 2 (2.2%) ns 3 (7.0%) 2 (1.5%) ns 2 (3.7%) 3 (2.5%) ns
Grade 3 IVH, PH or cystic PVL no. (%) 15 (17.6%) 5 (5.6%) nsa 9 (20.0%) 11 (8.3%) nsa 11 (20.3%) 9 (7.5%) nsa
VM, mechanical ventilation; IVH, intraventricular hemorrhage; PH, parenchymal hemorrhage; PVL, periventricular leukomalacia.
a
Logistic regression analysis performed to adjust for gestational age, birth weight and Apgar score at 5 min.
histological chorioamnionitis, funisitis and clinical chorioamnionitis. outcome. Nevertheless, the presence of funisitis signicantly in-
Birth weight was signicantly higher in patients lost to follow-up creased the odds of development of moderate to severe disabilities.
(1324 375 g vs 1189 302 g; P = 0.042). Neurodevelopmental out- Our diagnostic criteria for clinical chorioamnionitis detected 57% of
comes are shown in Table 3. The risk of moderate to severe disability cases of histological chorioamnionitis, whereas we had a 10% rate of
was increased by factor 4 in patients with funisitis (OR 4.07; 95% CI false positive clinical diagnoses of chorioamionitis. Our results are
1.1015.09), whereas the risk of disability of any grade was doubled in comparable to those of Redline et al., who also found an association
patients exposed to clinical chorioamnionitis compared to controls between clinically recognized cases of chorioamnionitis and fetal
(OR 2.33; 95% CI 1.035.25). Association between outcome variables inammatory involvement [33]. Furthermore, our study showed a
and placental lesions remained unchanged when analysis was relationship between clinical chorioamnionitis and development of
performed excluding multiple births. disabilities.
Gestational age was lower in our group of infants with chor-
4. Discussion ioamnionitis, suggesting that intrauterine infection/inammation is
usually associated to birth at earlier gestational ages than vascular or
In our study histological chorioamnionitis was present in the other causes of prematurity. We therefore controlled for gestational
placentas of 49% of very low birth weight infants, a gure similar to age in analysis, as well as for multiple pregnancy, birth weight and
that found by other authors [17,22,33,44]. Apart from a marginally Apgar score at 5 min. The lack of rigorous adjustment for confounding
signicant association with motor abnormalities, this condition was factors, mainly gestational age, may in part explain the relationship
not associated with an increased risk for adverse neurodevelopmental between histological chorioamnionitis and neurodevelopmental
Table 3
Neurodevelopmental outcomes of 130 infants grouped by the presence or absence of histological chorioamnionitis, funisitis and clinical chorioamnionitis.
Speech abnormalities no. (%) 15 (24.2%) 13 (19.1%) ns 12 (36.3%) 16 (16.5%) 0.05 13 (33.3%) 15 (16.5%) 0.039
Motor abnormalities
Any grade no. (%) 9 (14.5%) 3 (4.4%) 0.047 6 (18.2%) 6 (6.2%) ns 6 (15.4%) 6 (6.5%) ns
Cerebral palsy no. (%) 5 (8%) 2 (2.9%) ns 4 (12.1%) 3 (3.1%) 0.047 3 (7.7%) 4 (4.4%) ns
Cerebral palsy impairing walking no. (%) 2 (3.2%) 0 ns 2 (6%) 0 ns 1 (2.5%) 1 (1.1%) ns
Refractive disorder no. (%) 10 (16.1%) 12 (17.6%) ns 6 (18.1%) 16 (16.5%) ns 8 (20.5%) 14 (15.4%) ns
VEP abnormal result no. (%) 2 (3.2%) 0 ns 1 (3.0%) 1 (1.0%) ns 1 (2.5%) 1 (1.1%) ns
Hearing loss no. (%) 2 (3.2%) 3 (4.4%) ns 1 (3.0%) 4 (4.1%) ns 1 (2.5%) 4 (4.4%) ns
Behavioral disorder no. (%) 9 (14.5%) 8 (11.7%) nsa 4 (12.1%) 13 (13.4%) nsa 9 (23%) 8 (8.8%) nsa
Seizures no. (%) 3 (4.8%) 1 (1.5%) ns 3 (9.0%) 1 (1.0%) 0.05 2 (5.1%) 2 (2.2%) Ns
Disability
Any grade no. (%) 24 (38.7%) 23 (33.8%) nsb 14 (42.4%) 33 (34.0%) nsb 19(48.7%) 28 (30.7%) 0.045b
Moderate to severe no. (%) 7 (11.3%) 4 (5.9%) nsb 6 (18.1%) 5 (5.1%) 0.03b 5 (12.8%) 6 (6.6%) nsb
Severe no. (%) 2 (3.2%) 1 (1.5%) nsb 2 (6.0%) 1 (1.0%) nsb 1 (2.5%) 2 (2.2%) nsb
Developmental quotient (n = 40) (n = 51) (n = 21) (n = 70) (n = 22) (n = 69)
Median (range) 111 (75156) 108 (52133) ns 112 (75150) 108 (52156) ns 111 (75150) 108 (52156) ns
b70 no. (%) 0 (0%) 2 (3.9%) ns 0 (0%) 2 (2.9%) ns 0 (0%) 2 (2.9%) ns
7084 no. (%) 2 (5%) 1 (2.0%) ns 2 (9.5%) 1 (1.4%) ns 2 (9.1%) 1 (1.4%) ns
85 no. (%) 38 (95.0%) 48 (94.1%) ns 19 (90.5%) 67 (95.7%) ns 20 (90.9%) 66 (75.8%) ns
acute inammation and severe neurodevelopmental disability at 6 years of age. [41] Arce A, Iriondo M, Krauel J, Jimnez R, Campistol J, Poo P, et al. Seguimiento
Am J Obstet Gynecol 2008;198:466.e1466.e11. neurologico de recien nacidos menores de 1500 gramos a los dos aos de edad. An
[32] Schlapbach LJ, Ersch J, Adams M, Bernet V, Bucher HU, Latal B. Impact of Pediatr (Barc) 2003;59:45461.
chorioamnionitis and preeclampsia on neurodevelopmental outcome in preterm [42] Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage
infants below 32 weeks gestational age. Acta Paediatr 2010;99:15049. of the premature infant. Philadelphia: Saunders Elsevier; 2008. p. 51788.
[33] Redline RW, Wilson-Costello D, Borawski E, Fanaroff AA, Hack M. The relationship [43] de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial
between placental and other perinatal risk factors for neurologic impairment in ultrasound. Behav Brain Res 1992;49:16.
very low birth weight children. Pediatr Res 2000;47:7216. [44] Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors
[34] Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, et al. Clinical signicance of for chronic lung disease in very low birth weight infants. Pediatr Res 2002;52:
intra-amniotic inammation in patients with preterm labor and intact mem- 7139.
branes. Am J Obstet Gynecol 2001;185:11306. [45] Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, et al.
[35] Wharton KN, Pinar H, Stonestreet BS, Tucker R, McLean KR, Wallach M, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal
Severe umbilical cord inammation-a predictor of periventricular leukomalacia in inammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:1825.
very low birth weight infants. Early Hum Dev 2004;77:7787. [46] Katzman PJ, Metlay LA. Fetal inammatory response is often present at early
[36] Redline RW, Minich N, Taylor HG, Hack M. Placental lesions as predictors of stages of intra-amniotic infection, and its distribution along cord is variable.
cerebral palsy and abnormal neurocognitive function at school age in extremely Pediatr Dev Pathol 2010;13:26572.
low birth weight infants (b1 kg). Pediatr Dev Pathol 2007;10:28292. [47] Nelson KB, Dambrosia JM, Iovannisci DM, Cheng S, Grether JK, Lammer E. Genetic
[37] Fernndez E. Taula de desenvolupament psicomotor. Generalitat de Catalunya1. polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 2005;57:
edici. . Barcelona: Departament de Sanitat i Seguretat Social; 1988. 4949.
[38] Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: [48] Wu YW, Croen LA, Torres AR, Van De Water J, Grether JK, Hsu NN. Interleukin-6
Psychological Corporation; 1993. genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol
[39] Brunet-Lezine JD, Josse D. Brunet-Lezine Rvis: chelle de Dveloppement 2009;66:66370.
Psychomoteur de la Premire Enfance. Paris, France: Etablissement d'Applications [49] Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard
Psychotechniques; 1997. Dev Disabil Res Rev 2002;8:259.
[40] Iriondo M, Martinez F, Navarro A, Campistol J, Ibaez M, Krauel J. Recien nacidos [50] Hart AR, Whitby EW, Grifths PD, Smith MF. Magnetic resonance imaging and
de muy bajo peso (b1500 g). Mortalidad y seguimiento evolutivo a los dos aos. developmental outcome following preterm birth: review of current evidence. Dev
Arch Pediatr 1996;47:2631. Med Child Neurol 2008;50:65563.